PMCB earnings date and last-quarter result: last quarter beat, P/E -0.59. Updated 2026-07-23.
PharmaCyte Biotech (PMCB) Research Hub
PharmaCyte Biotech (PMCB) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 0.3501 USD (-1.44%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.59, market cap 0.00B. This hub links to the full technical, earnings and options research available for PMCB.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 0.3501 USD (-1.44%) |
| 52-week range | 0.3339 USD – 0.84 USD |
| Trend regime | Range |
| 14-day RSI | 23 (Oversold) |
| Trailing P/E | -0.59 |
| Market cap | 0.00B |
| Dividend yield | 0.00% |
Available research for PMCB
Covered Call on PMCB: how it works, illustrative setup around the real 0.3501 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on PMCB: how it works, illustrative setup around the real 0.3501 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on PMCB: how it works, illustrative setup around the real 0.3501 USD price, max profit/loss, breakeven and when to use it. Educational.
PMCB technical analysis: range, last 0.3501 USD, RSI 23, 52w range 0.3339 USD–0.84 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is PMCB in?
PharmaCyte Biotech (PMCB) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is PMCB in an uptrend or downtrend?
As of 2026-10-26, PMCB is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is PMCB's trailing P/E ratio?
PMCB's trailing P/E is -0.59, with a market cap of 0.00B. See the earnings research page for full valuation detail.